History

The brothers Shoichi and Shigeru Yamanaka established an optical glass production plant in the city of HOYA, Tokyo, and production of optical glass began.

HOYA´s First Plant

The plant incorporated with capital of 1.2 million yen.

HOYA launched crystal products.

Crystal Stemware

HOYA listed on the Second Section of the Tokyo Stock Exchange.

The company launched progressive multifocal lenses.

HOYA Started Sales of soft contact lenses.

The Company listed on the First Section of the Tokyo Stock Exchanges.

The company began production of IC substrates.

The company was renamed Hoya Corporation, and the new Head Office building is completed.

The company established R&D Center bldg. in the city of Akishima.

HOYA launched intraocular lenses (IOLs) as well as aspherical molded-glass lenses.

HOYA established HOYA Holdings N.V. of the Netherlands and HOYA Corporation USA to reinforce global management.

HOYA Holdings N.V., of the Netherlands.

HOYA launches glass disks for HDDs.

First Group’s Philosophy of Environment issued.

HOYA invited first outside director.

HOYA formed an alliance with IBM to develop a next-generation glass disk for HDDs.

Hoya establishes HOYA Holdings Asia Pacific Pte Ltd, as the third regional area HQ after HOYA Holdings N.V. and HOYA Holdings, Inc., the area HQs for Europe and North America, respectively.

HOYA launches HOYALUX Summit Pro and NuLux lenses that use EYRY, a high-index, plastic lens material.

HOYA begins manufacturing soft intraocular lenses.

HOYA establishes a company-with-committees system.

HOYA transfers its global financial management operations to an area HQ in Europe.

HOYA common stock splits four-for-one.

As a result of the Tender Offer, PENTAX became a consolidated subsidiary of HOYA.

HOYA and PENTAX merged.

HOYA terminated the Crystal business.

HOYA sold the hard disk glass media manufacturing operation.

Disclosed its consolidated financial statements in accordance with first-time adoption of IFRSs for the fiscal year ended March 31, 2010 on its web site.
(Voluntarily filed its consolidated financial statements under IFRS from the fiscal year ended March 31, 2011.)

HOYA sold PENTAX Imaging Systems business to Ricoh Company, Ltd.

Eyeglass business expanded its direct presence in Brazil by acquiring 100% shares of OPTOTAL HOYA LIMITADA.

Next generation High Definition (HD+) Endoscopic platform debuted.

HOYA, SEIKO and EPSON; Agreements executed in the field of optical products business.

HOYA acquired eyeglass lens development and manufacturing business from Seiko Epson Corporation.

HOYA acquired 30% of the shares of Seiko Optical Products Co. Ltd., a wholly owned subsidiary of SEIKO Holdings Corporation responsible for the sales of the eyeglass-related products.

HOYA acquired the majority shares of Wassenburg, a leading company in the field of endoscope reprocessing.

Hoya completed the acquisition of a 50% stake in Seiko Optical Products that became a consolidated subsidiary.

HOYA introduced newly developed optics glass blanks called “NRP”.

Hoya invested in SalutarisMD Wet AMD Therapy Technology.

PENTAX Medical launched Splash M-Knife, The New Multi-Functional ESD Device.

Farewell Ceremony held for the Late Honorary Chairman Tetsuo Suzuki.

PENTAX Medical invested in Creo Medical Ltd., a leading electrosurgical energy devices company in the U.K.

HOYA reached agreement to acquire Swiss lens manufacturer Knecht & Muller AG.

HOYA made Additional Investment in InnFocus, Inc., a Glaucoma Device Company.

HOYA group headquarters relocated to the West Side of Shinjuku Station, Tokyo.

HOYA launches Yuniku, a global first in vision-centric,3D tailored eyewear.

Executed Definitive Agreement to Acquire Performance Optics, LLC and its subsidiaries.

PENTAX Medical Launch HemoStat WideCup, The New Bipolar Hot Hemostasis Forceps Cancer.

HOYA Vision Care acquired safety prescription eyewear business from 3M.
PENTAX Medical acquired C2 Therapeutics to expand Interventional Endoscopy Offering.

PENTAX Medical Expands Interventional Endoscopy Offering with Acquisition of C2 Therapeutics.

HOYA Won Corporate Governance of the Year Grand Prize.

HOYA Group Certified as an Excellent Enterprise of Health and Productivity Management.

HOYA Makes Medical Device Venture Investment in LensGen, Inc., an Accommodating Intraocular Lens Developing company.

C-PUS and speech synthesis business transferred from HOYA Service to HOYA Corporation.

PENTAX Medical and Chinese company Aohua Established Flexible Medical Endoscopy Joint Venture.
HOYA acquired Readspeaker, the leading cloud-base Text to Speech company.
HOYA Surgical Optics opened IOL manufacturing facility in Thailand.

HOYA completed the acquisition of Performance Optics Group including VISION EASE and Dameon.

HOYA Surgical Optics Launched global research and development centre in Singapore.

HOYA Surgical Optics acquired medical device companies: US-based Mid Labs and Germany-based Fritz Ruck.

HOYA absorbed and merged HOYA CANDEO OPTRONICS Corporation.

HOYA Surgical Optics established a new joint venture with GeMax,a specialty promotion service provider of IOLs in China.

PENTAX Medical and Vedkang Establish Endoscopic Therapeutics Joint Venture.

HOYA announces endorsement of recommendations by the Task Force on Climate-Related Financial Disclosures (TCFD).

HOYA sold HOYA Digital Solutions Corporation to FUJIFILM Business Innovation Corporation.

HOYA Vision Care entered into Joint Venture with Jiangsu Sigo Optical, Chinese eyeglass lens manufacturer.

HOYA joined the Japan Climate Leaders Partnership (JCLP),  a group of companies committed to realizing a sustainable decarbonized society.

HOYA established a Joint Venture with BOE Group for FPD photomask business in China.

HOYA joined the United Nations Global Compact, the world’s largest sustainability initiative to build a healthy global society.

HOYA joined RE100 International Environmental Initiative aiming to achieve 100% renewable electricity.

HOYA Certified as an Excellent Enterprise of Health and Productivity Management for the seventh consecutive year.